Successful product evaluations of the PS laparoscopic and surgical stapling portfolios has resulted in significant cost-savings for an NHS Trust in the south-east.



After an analysis of the current range of laparoscopic and surgical stapling instruments and devices used by one NHS Trust in the South East, our Senior Territory Manager for Purple Surgical, Katie Boorer, put together a proposal identifying ways in which savings could be made by the Head of Procurement .

Purple Surgical Laparoscopic, Operating Theatre and Surgical Stapling portfolios were introduced and a ‘price usage’ exercise concluded that by consolidating the supply of the laparoscopic and stapling devices used by the Trust solely to Purple Surgical, significant cost savings could be made.


Clinical Product Evaluations

Consultants and theatre staff trialled the products and after initial feedback, approval for extensive clinical evaluations was given.

Katie attended every procedure to ensure that the surgeon’s preferences were met and that PS products performed to the expected standard. Before every procedure a demonstration of the devices and instruments was carried out to ensure that surgeons and staff were confident and comfortable. Katie was on hand to answer questions from consultants and theatre staff as and when they arose.


Challenges and Resolutions

  • Consultants were concerned with their current Hasson Balloon Obturator as the tip was felt to be too sharp. Replacing it with the PS Essential Hasson Trocar resolved this issue as the tip on our product is blunt.
  • Our Bipolar Forceps were found to be particularly useful in gynaecological procedures for haemostasis when used in conjunction with the Lotus.
  • PS stapling devices are supplied with reload units whereas the current brand were not, resulting in additional cost savings.


Outcomes and Conclusions:

Switching to the Purple Surgical Laparoscopic and Surgical Stapling instruments and devices has resulted in significant cost-savings for this Trust, and has reduced unwarranted product variations.

Following the success of these clinical trials we have built trust with the procurement team and operating theatre staff to examine cost savings in other areas.

With the implementation of weekly reports, to KOLs, to constantly support and update, we have been able to secure a cost-saving of over £40,000 for this Trust.